E-LIB Suche - Ergebnisse für: Sager, Philip T.

1

PO-01-046 ATTENUATION OF DRUG-INDUCED QT-PROLONGATION IN GU..:

Gralinski, Michael R. ; Doherty, Kimbery ; Pradhananga, Sabindra...
Heart Rhythm. 21 (2024) 5 - p. S187-S188 , 2024

Link: https://doi.org/10.1016/..

2

Self-administered intranasal etripamil using a symptom-prom..:

Stambler, Bruce S ; Camm, A John ; Alings, Marco...
The Lancet. 402 (2023) 10396 - p. 118-128 , 2023

Link: https://doi.org/10.1016/..

3

SGK1 inhibition attenuated the action potential duration in..:

Kim, Maengjo ; Das, Saumya ; Tester, David J....
Heart Rhythm O2. 4 (2023) 4 - p. 268-274 , 2023

Link: https://doi.org/10.1016/..

4

Gene- and variant-specific efficacy of serum/glucocorticoid..:

Giannetti, Federica ; Barbieri, Miriam ; Shiti, Assad...
Europace. , 2023

Link: https://doi.org/10.1093/..

5

A Phase 1 Clinical Study Evaluating the Effects of Cenobama..:

Darpo, Borje ; Sager, Philip T. ; Xue, Hongqi.
Clinical Pharmacology in Drug Development. 11 (2022) 4 - p. 523-534 , 2022

Link: https://doi.org/10.1002/..

6

First Randomized, Multicenter, Placebo-Controlled Study of ..:

Stambler, Bruce S. ; Plat, Francis ; Sager, Philip T....
Circulation: Arrhythmia and Electrophysiology. 15 (2022) 12 - p. , 2022

Link: https://doi.org/10.1161/..

7

Rationale for and design of a multicenter, placebo-controll..:

Stambler, Bruce S. ; Plat, Francis ; Sager, Philip T....
American Heart Journal. 253 (2022) - p. 20-29 , 2022

Link: https://doi.org/10.1016/..

8

Why translation from basic discoveries to clinical applicat..:

Nattel, Stanley ; Sager, Philip T ; Hüser, Jörg..
Cardiovascular Research. 117 (2021) 7 - p. 1616-1631 , 2021

Link: https://doi.org/10.1093/..

9

Electrophysiological and ECG Effects of Perhexiline, a Mixe..:

Midei, Mark G. ; Darpo, Borje ; Ayers, Greg...
The Journal of Clinical Pharmacology. 61 (2021) 12 - p. 1606-1617 , 2021

Link: https://doi.org/10.1002/..

10

Methodological and Regulatory Considerations for Updated Gu..:

Harrison, Nicholas R. ; Sager, Philip T. ; Krucoff, Mitchell W...
Therapeutic Innovation & Regulatory Science. 54 (2020) 6 - p. 1473-1476 , 2020

Link: https://doi.org/10.1007/..

11

The Potential Role of the J‐Tpeak Interval in Proarrhythmic..:

Vicente, Jose ; Strauss, David G. ; Upreti, Vijay V....
The Journal of Clinical Pharmacology. 59 (2019) 7 - p. 909-914 , 2019

Link: https://doi.org/10.1002/..

12

Assessment of Multi‐Ion Channel Block in a Phase I Randomiz..:

Vicente, Jose ; Zusterzeel, Robbert ; Johannesen, Lars...
Clinical Pharmacology & Therapeutics. 105 (2019) 4 - p. 943-953 , 2019

Link: https://doi.org/10.1002/..

13

Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update fr..:

Strauss, David G. ; Gintant, Gary ; Li, Zhihua...
Therapeutic Innovation & Regulatory Science. 53 (2019) 4 - p. 519-525 , 2019

Link: https://doi.org/10.1177/..

14

Correction: Electrocardiographic Biomarkers for Detection o..:

Vicente, Jose ; Johannesen, Lars ; Hosseini, Meisam...
PLOS ONE. 13 (2018) 5 - p. e0197952 , 2018

Link: https://doi.org/10.1371/..

15

Is there a role for pharmacokinetic/pharmacodynamic-guided ..:

Chan, Noel ; Sager, Philip T. ; Lawrence, Jack...
American Heart Journal. 199 (2018) - p. 59-67 , 2018

Link: https://doi.org/10.1016/..